Fisher Asset Management’s Celldex Therapeutics CLDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$32.2M	Buy	1,013,648 +76,490	+8%	+$2.09M	0.01%	279
2025 Q4	$25.5M	Buy	937,158 +10,001	+1%	+$263K	0.01%	295
2025 Q3	$24M	Buy	927,157 +104,949	+13%	+$2.43M	0.01%	301
2025 Q2	$16.7M	Sell	822,208 -49,420	-6%	-$962K	0.01%	343
2025 Q1	$15.8M	Buy	871,628 +419,131	+93%	+$9.36M	0.01%	353
2024 Q4	$11.4M	Buy	452,497 +78,145	+21%	+$2.12M	﹤0.01%	416
2024 Q3	$12.7M	Buy	374,352 +253,808	+211%	+$9.67M	0.01%	389
2024 Q2	$4.46M	Sell	120,544 -3,292	-3%	-$124K	﹤0.01%	498
2024 Q1	$5.2M	Buy	123,836 +102,024	+468%	+$4.19M	﹤0.01%	502
2023 Q4	$865K	Buy	21,812 +1,274	+6%	+$37.5K	﹤0.01%	710
2023 Q3	$565K	Hold	20,538	–	–	﹤0.01%	835
2023 Q2	$697K	Hold	20,538	–	–	﹤0.01%	833
2023 Q1	$739K	Sell	20,538 -8,479	-29%	-$366K	﹤0.01%	806
2022 Q4	$1.29M	Sell	29,017 -4,876	-14%	-$174K	﹤0.01%	723
2022 Q3	$953K	Buy	+33,893	New	+$1.04M	﹤0.01%	680